Orthofix Medical Inc. Common Stock (DE) (NASDAQ: OFIX)
15 Days left to seek lead plaintiff status.
The Complaint alleges that throughout the Class Period, Defendants issued false and misleading statements and/or failed to disclose adverse facts about the Company’s management team. The Complaint further alleges that when the truth about the Company’s management team was revealed, the price of Orthofix common stock suffered sharp declines and that as a result, Plaintiff and other Class members suffered significant losses and damages.